Business Context and Reporting Period
This Form 8-K Current Report was filed by Enochian Biosciences Inc. (trading symbol: ENOB) on June 24, 2020. The filing reports on the results of the Company's annual meeting of stockholders held on that date. The registrant is a Delaware corporation with principal executive offices in Los Angeles, CA, and is classified as an emerging growth company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and does not contain financial performance data.
Material Changes and Voting Results
The filing details the outcomes of two proposals submitted to stockholders:
- Proposal No. 1: Election of Directors. Stockholders elected eight directors for terms until the next annual meeting. All nominees received significant majority support, with "Votes For" ranging from approximately 31.0 million to 31.8 million shares. "Votes Withheld" ranged from approximately 44,000 to 821,000 shares. There were 1,543,006 broker non-votes for each director.
- Proposal No. 2: Ratification of Auditors. Stockholders ratified Sadler, Gibb & Associates, LLC as the independent registered public accounting firm. The vote count was 33,297,266 "For," 81,322 "Against," and 1 "Abstention."
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to the disclosure of voting results as required by Item 5.07.
Investor Verification Checklist
- Verify the current status of the newly elected board members and their tenure.
- Confirm the engagement of Sadler, Gibb & Associates, LLC as the independent auditor for the upcoming fiscal period.
- Review the Proxy Statement filed on May 22, 2020, for detailed biographies of directors and the rationale for the auditor selection.
- Check subsequent filings (e.g., 10-Q or 10-K) for the financial metrics absent in this 8-K.